AMEXDRUG CORPORATION
8909 West Olympic Boulevard, Suite 208
Beverly Hills, California 90211
July 22, 2009
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: | Amexdrug Corporation |
Form 10-K for the year ended December 31, 2008 |
filed on April 13, 2009 |
Form 10-Q for the quarter ended March 31, 2009 |
Filed on May 14, 2009 |
File No. 0-7473 |
Ladies and Gentlemen:
In response to the Commission’s letter to Amexdrug Corporation of July 2, 2009, this letter will confirm the following:
1.Amexdrug Corporation is responsible for the adequacy and accuracy of the disclosure in the filing;
2.Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
3.Amexdrug Corporation may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions concerning this letter which has been provided at your request, please let me know.
Sincerely,
AMEXDRUG CORPORATION
/s/ Jack Amin
Jack Amin
Chief Executive Officer